Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | THRB | P10828 | 2/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | GAA | P10253 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | GFER | P55789 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL565079 | 0.91 | ALOX15 (0.54) | CYP3A4ALOX15TDP1ALDH1A1RECQL | |
| SCHEMBL564670 | 0.88 | CYP3A4 (0.52) | CYP3A4ALOX15TDP1ALDH1A1RECQL | |
| SCHEMBL564600 | 0.86 | ALDH1A1 (0.54) | CYP3A4ALOX15TDP1ALDH1A1RECQL | |
| SCHEMBL563872 | 0.83 | ALDH1A1 (0.61) | CYP3A4ALOX15TDP1ALDH1A1RECQL | |
| SCHEMBL17506803 | 0.82 | ALOX15 (0.47) | CYP3A4ALOX15TDP1ALDH1A1RECQL | |
| SCHEMBL564726 | 0.82 | CYP3A4 (0.60) | CYP3A4ALOX15TDP1ALDH1A1RECQL | |
| SCHEMBL477516 | 0.82 | ALDH1A1 (0.59) | CYP3A4ALOX15TDP1ALDH1A1RECQL | |
| SCHEMBL8092870 | 0.80 | TDP1 (1.00) | CYP3A4ALOX15TDP1ALDH1A1RECQL | |
| SCHEMBL565035 | 0.79 | MAPT (0.60) | CYP3A4ALOX15TDP1ALDH1A1RECQL | |
| SCHEMBL306231 | 0.76 | ALDH1A1 (0.57) | CYP3A4ALOX15TDP1ALDH1A1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8674029-B2 | Method of preparing stabilized polymeric systems using polymeric peroxides | Sunocs LLC (US) | 2014-03-18 | — | — | US | disclosed |
| US-20120035307-A1 | PROCESS FOR MAKING STABLIZED POLYMERIC SYSTEMS WITH NANOSTRUCTURES | SONG CHENGQIAN (US) | 2012-02-09 | — | — | US | disclosed |
| US-20120035315-A1 | METHOD OF PREPARING STABLIZED POLYMERIC SYSTEMS USING POLYMERIC PEROXIDES | SONG CHENGQIAN (US) | 2012-02-09 | — | — | US | disclosed |
| US-7498467-B2 | Antioxidant and bisaminophenol derivative | IDEMITSU KOSAN CO., LTD. (JP) | 2009-03-03 | — | — | US | disclosed |
| US-20080161608-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | IDEMITSU KOSAN CO., LTD. (JP) | 2008-07-03 | — | — | US | disclosed |
| US-20060208227-A1 | Antioxidant and bisaminophenol derivative | IDEMITSU LOSAN CO., LTD (JP) | 2006-09-21 | — | — | US | disclosed |
| EP-1612254-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2006-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161608-A1 | ANTIOXIDANT AND BISAMINOPHENOL DERIVATIVE | CBR1, CBR3, HMOX1 | CYP3A4 360/4885ALOX15 1352/4885TDP1 1337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.